# NEPH-ROSIS (NEPHrology in CirRhOSIS) Pilot Trial: A Trial to Treat Acute Kidney Injury Among Hospitalized Cirrhosis Patients

> **NCT06000748** · PHASE2,PHASE3 · TERMINATED · sponsor: **University of California, San Francisco** · enrollment: 6 (actual)

## Conditions studied

- Acute Kidney Injury
- Cirrhosis
- Portal Hypertension
- Hepatorenal Syndrome
- Acute Tubule Necrosis
- Prerenal Failure

## Interventions

- **DRUG:** MAP-Target Algorithm

## Key facts

- **NCT ID:** NCT06000748
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2024-02-01
- **Primary completion:** 2024-07-31
- **Final completion:** 2024-07-31
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Investigator Left Institution
- **Last updated:** 2025-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06000748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06000748, "NEPH-ROSIS (NEPHrology in CirRhOSIS) Pilot Trial: A Trial to Treat Acute Kidney Injury Among Hospitalized Cirrhosis Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06000748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*